{"id":73303,"date":"2024-02-02T15:30:49","date_gmt":"2024-02-02T15:30:49","guid":{"rendered":"https:\/\/entertainment.runfyers.com\/index.php\/2024\/02\/02\/sample-series-a-pitch-deck-phagelabs-11m-deck-techcrunch\/"},"modified":"2024-02-02T15:30:49","modified_gmt":"2024-02-02T15:30:49","slug":"sample-series-a-pitch-deck-phagelabs-11m-deck-techcrunch","status":"publish","type":"post","link":"https:\/\/entertainment.runfyers.com\/index.php\/2024\/02\/02\/sample-series-a-pitch-deck-phagelabs-11m-deck-techcrunch\/","title":{"rendered":"Sample Series A pitch deck: PhageLab’s $11M deck | TechCrunch"},"content":{"rendered":"


\n<\/p>\n

\n

As a species<\/span>, we have a problem. Bacteria are becoming more and more resistant to antibiotics. Makes sense: Antibiotics kill off all the bacteria they can, but the remaining ones that somehow survive continue to grow and spread. Guess which gene they all have in common? That\u2019s right, the one that makes them resistant to antibiotics.<\/p>\n

We\u2019ve known this for years, but instead of accelerating, the work on new antibiotics is slowing down significantly. Why? Capitalism: It\u2019s really expensive to develop new drugs, and once they\u2019re developed, it\u2019s hard to make a lot of money on them.<\/p>\n

PhageLab<\/a> wants to come to the rescue with a different approach: using a phage (short for \u201cbacteriophage\u201d). Phages are a type of virus that infects bacteria and kills them. Unlike traditional antibiotics, phages can be designed to target very specific bacteria, and that lets us use them to kill only the bacteria you don\u2019t want (say, salmonella), while your gut bacteria stay more or less intact.<\/p>\n

Of course, the process is not without downsides. One of the reasons broad-spectrum antibiotics work so well is that doctors often don\u2019t know exactly which bacteria are wreaking havoc, and if you have a phage that attacks only a handful of bacteria, that could pose a challenge.<\/p>\n

Still, I love phages in general, and the idea behind PhageLab is pretty rad. The team shared their pitch deck with me, so let\u2019s see what the company showed investors to raise its $11 million Series A round.<\/p>\n\n

We\u2019re looking for more unique pitch decks to tear down, so if you want to submit your own, here\u2019s how you can do that<\/a>.<\/em><\/p>\n\n

Slides in this deck<\/h2>\n

The page numbering on the deck is wonky (Page 1 is labeled 1, but page 3 is labeled 2) so keep in mind that when I refer to slide numbers in this teardown, I\u2019m referring to the page number of the PDF, not what\u2019s on the slides themselves. The final slide is page 26 of the PDF, but it is labeled 32, so it\u2019s clear that some slides were deleted from the deck before PhageLab shared it with me. The company says the use of funds slide has been removed, but it\u2019s not entirely clear what else was deleted.<\/p>\n

Still, let\u2019s review this deck as if this were the full story and see where that takes us.<\/p>\n

    \n
  1. Cover slide<\/li>\n
  2. Summary slide<\/li>\n
  3. Problem slide<\/li>\n
  4. Problem overview slide<\/li>\n
  5. Problem impact slide I<\/li>\n
  6. Problem context slide<\/li>\n
  7. Problem summary slide<\/li>\n
  8. Problem impact slide II<\/li>\n
  9. Problem impact slide III<\/li>\n
  10. \u00a0 Market size slide<\/li>\n
  11. \u00a0\u201cThis is how we do it\u201d interstitial slide<\/li>\n
  12. \u00a0 Value proposition slide<\/li>\n
  13. \u00a0 \u201cWhat are phages\u201d slide<\/li>\n
  14. \u00a0 Why now slide<\/li>\n
  15. \u00a0 Solution slide I<\/li>\n
  16. \u00a0 Solution slide II<\/li>\n
  17. \u00a0 Field trial results slide<\/li>\n
  18. \u00a0 \u201cMeet our team\u201d interstitial slide<\/li>\n
  19. \u00a0 Team size slide<\/li>\n
  20. \u00a0 Headquarters slide<\/li>\n
  21. \u00a0 Team slide<\/li>\n
  22. \u00a0 Summary slide<\/li>\n
  23. \u00a0 Closing slide<\/li>\n
  24. \u00a0 Contact slide<\/li>\n
  25. \u00a0 Appendix interstitial slide<\/li>\n
  26. \u00a0 Appendix: Videos slide<\/li>\n<\/ol>\n

    Three things to love<\/h2>\n

    There\u2019s some truly fantastic storytelling in this deck.<\/p>\n

    So what about big pharma?<\/h3>\n

    Startups in this space always have to worry about the big pharma companies. They can definitely outspend you, so the question is how you\u2019re going to outsmart them.<\/p>\n

    <\/p>\n

    [Slide 6] Well that\u2019s how you compete: They have given up. Image Credits<\/strong>: PhageLab<\/p>\n<\/div>\n

    This slide goes a long way toward answering that: The business case for developing new antibiotics is plummeting, which opens the door for PhageLab.<\/p>\n

    That makes the urgency clear\u00a0.\u00a0.\u00a0.<\/h3>\n
    \"\"<\/p>\n

    [Slide 9] Yeah, that\u2019ll get their attention. Image Credits<\/strong>: PhageLab<\/p>\n<\/div>\n

    I do have a thing or two to say about how the company outlines its problem statement, but slide 9 made me catch my breath. If we are 25 years away from this doomsday scenario, it\u2019s obvious that there\u2019s a huge opportunity for startups that can make a real impact in this space. It\u2019s powerful storytelling.<\/p>\n

    That\u2019s a hell of a promise of success<\/h3>\n
    \"\"<\/p>\n

    [Slide 17] So does it work? Image Credits<\/strong>: PhageLab<\/p>\n<\/div>\n

    Bacteria are pretty nebulous, so where do you even begin? It seems to me like PhageLab asked itself: What\u2019s a bacteria that everyone knows exists, knows where <\/em>it exists, and is often in the media? Salmonella fits the bill nicely. The company has done its research and reckons it can remove salmonella altogether \u2014 a huge and obvious benefit for food supply chains.<\/p>\n

    In the rest of this teardown, we\u2019ll take a look at three things PhageLab could have improved or done differently, along with its full pitch deck!<\/p>\n<\/p><\/div>\n


    \n
    Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

    As a species, we have a problem. Bacteria are becoming more and more resistant to antibiotics. Makes sense: Antibiotics kill off all the bacteria they can, but the remaining ones that somehow survive continue to grow and spread. Guess which gene they all have in common? That\u2019s right, the one that makes them resistant to […]<\/p>\n","protected":false},"author":1,"featured_media":73304,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":{"0":"post-73303","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-tech"},"_links":{"self":[{"href":"https:\/\/entertainment.runfyers.com\/index.php\/wp-json\/wp\/v2\/posts\/73303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/entertainment.runfyers.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/entertainment.runfyers.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/entertainment.runfyers.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/entertainment.runfyers.com\/index.php\/wp-json\/wp\/v2\/comments?post=73303"}],"version-history":[{"count":0,"href":"https:\/\/entertainment.runfyers.com\/index.php\/wp-json\/wp\/v2\/posts\/73303\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/entertainment.runfyers.com\/index.php\/wp-json\/wp\/v2\/media\/73304"}],"wp:attachment":[{"href":"https:\/\/entertainment.runfyers.com\/index.php\/wp-json\/wp\/v2\/media?parent=73303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/entertainment.runfyers.com\/index.php\/wp-json\/wp\/v2\/categories?post=73303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/entertainment.runfyers.com\/index.php\/wp-json\/wp\/v2\/tags?post=73303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}